Educational Programs for You and Your Staff

Get the latest news on canine inappetence and ENTYCE® (capromorelin oral solution), the only FDA-approved veterinary therapeutic for stimulating appetite in dogs.

Conferences

Learn more about ENTYCE at Aratana Therapeutics educational sessions or by stopping by our booth at these upcoming conferences.

September 13-17

IVECCS 2018

September 13-17, 2018
New Orleans, LA

October 18-20

VCS

October 18-20, 2018
Louisville, KY

October 24-27

ACVS

October 24-27, 2018
Phoenix, AZ

November 8-9

New York Vet Conference

November 8-9, 2018
New York, NY

Webinars

Join an upcoming live webinar from the convenience of your home or office. These online sessions are provided at no cost to you as an educational service by Aratana Therapeutics.

September 13

Dealing With Dysrexia
1-hour RACE CE webinar*
Provided by DVM 360

September 13, 2018
1:00 p.m. ET
12:00 p.m. CT

Presented by Audrey Cook, BVM&S, MRCVS, DACVIM-SAIM, DECVIM-CA, DABVP (Feline Practice)

Dr. Cook graduated with BVM&S (with Distinction) from University of Edinburgh. She completed an Internship in Small Animal Medicine and Surgery at NCSU and a residency in SA Internal Medicine at UC Davis. She is a Diplomate of both the American and European Colleges of Veterinary Internal Medicine, and the American Board of Veterinary Practitioners (Feline Practice). From 1997 to 2007, Audrey Cook owned a specialty referral practice in Virginia, before joining the faculty at Texas A&M. She is currently Associate Professor in Small Animal Internal Medicine, with particular interests in endocrinology and gastroenterology.

September 25

Dealing With Dysrexia
1-hour RACE CE webinar*

September 25, 2018
12:30 p.m. ET
11:30 a.m. CT

Presented by Audrey Cook, BVM&S, MRCVS, DACVIM-SAIM, DECVIM-CA, DABVP (Feline Practice)

Dr. Cook graduated with BVM&S (with Distinction) from University of Edinburgh. She completed an Internship in Small Animal Medicine and Surgery at NCSU and a residency in SA Internal Medicine at UC Davis. She is a Diplomate of both the American and European Colleges of Veterinary Internal Medicine, and the American Board of Veterinary Practitioners (Feline Practice). From 1997 to 2007, Audrey Cook owned a specialty referral practice in Virginia, before joining the faculty at Texas A&M. She is currently Associate Professor in Small Animal Internal Medicine, with particular interests in endocrinology and gastroenterology.

October 3

Dealing With Dysrexia
1-hour RACE CE webinar*

October 3, 2018
12:30 p.m. PT

Presented by Audrey Cook, BVM&S, MRCVS, DACVIM-SAIM, DECVIM-CA, DABVP (Feline Practice)

Dr. Cook graduated with BVM&S (with Distinction) from University of Edinburgh. She completed an Internship in Small Animal Medicine and Surgery at NCSU and a residency in SA Internal Medicine at UC Davis. She is a Diplomate of both the American and European Colleges of Veterinary Internal Medicine, and the American Board of Veterinary Practitioners (Feline Practice). From 1997 to 2007, Audrey Cook owned a specialty referral practice in Virginia, before joining the faculty at Texas A&M. She is currently Associate Professor in Small Animal Internal Medicine, with particular interests in endocrinology and gastroenterology.

*This program 1112-32188 is approved by the AAVSB RACE to offer a total of 1.00 CE credits (1.00 max) being available to any one veterinarian and/or 1.00 Veterinary Technician CE credits (1.00 max). This RACE approval is for the subject matter categories of: Category Two: Non-Scientific-Clinical using the delivery method of Seminar/Lecture Interactive-Distance. This approval is valid in jurisdictions that recognize AAVSB RACE; however, participants are responsible for ascertaining each board’s CE requirements. RACE does not “accredit” or “endorse” or “certify” any program or person, nor does RACE approval validate the content of the program.

IMPORTANT SAFETY INFORMATION: ENTYCE® (capromorelin oral solution) is for use in dogs only. Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. Should not be used in dogs that have a hypersensitivity to capromorelin. Please see the full Prescribing Information for more detail.

Other therapeutics from Aratana

Nocita® (bupivacaine liposome injectable suspension)
NOCITA® (bupivacaine liposome injectable suspension) is the only long-acting local anesthetic that controls post-op pain with one dose at the source for up to 72 hours following canine cranial cruciate ligament surgery or feline onychectomy to help patients recover comfortably. 

Visit Website >

DOG INDICATION: For single-dose infiltration into the surgical site to provide local post-operative analgesia for cranial cruciate ligament surgery in dogs.

IMPORTANT SAFETY INFORMATION: NOCITA® (bupivacaine liposome injectable suspension) is for local infiltration injection in dogs only. Do not use in dogs younger than 5 months of age, that are pregnant, lactating or intended for breeding. Do not administer by intravenous or intra-arterial injection. Adverse reactions in dogs may include discharge from incision, incisional inflammation and vomiting. Avoid concurrent use with bupivacaine HCl, lidocaine or other amide local anesthetics. Please see the full Prescribing Information for more detail.

CAT INDICATION: For use as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats.

IMPORTANT SAFETY INFORMATION: NOCITA® (bupivacaine liposome injectable suspension) is for use as a peripheral nerve block in cats only. Do not use in cats younger than 5 months of age, that are pregnant, lactating, or intended for breeding. Do not administer by intravenous or intra-arterial injection. Adverse reactions in cats may include elevated body temperature, infection or chewing/licking at the surgical site. Avoid concurrent use with bupivacaine HCl, lidocaine or other amide local anesthetics. Please see the full Prescribing Information for more detail.